AUM Biosciences will be presenting at the BIO Asia International Conference.

Hyderabad, India, 25 – 27 February 2019

AUM Biosciences will be presenting at the BIO Asia International Conference to be held in Hyderabad, India on the 25th to 27th February 2019. We are happy to be able to share out ideas on the theme of Life Sciences 4.0, Disrupt the disruption.

Details about the event can be found here: http://2019.bioasia.in/index.html

For more information, please contact pr@aumbiosciences.com

About AUM Biosciences

AUM Biosciences (AUM) is an oncology-focused Asian biotechnology company committed to developing affordable cancer therapies. Dedicated to unlocking the value in innovation, AUM harnesses the power of precision medicine and digital health to support patients, physicians and partners. AUM focuses on earlystage development of innovative treatment of cancers prevalent in Asia with the potential to address global markets.

AUM develops potent and highly selective therapeutics in oncology, with an aim to change the drug development paradigm by implementing a holistic approach to developing drugs. AUM Biosciences is led by a highly-experienced management team with over 75 years of high-quality oncology drug development experience combined.

Headquartered in Singapore, AUM is strategically positioned to work, partner and collaborate with leading research institutes, clinicians and pharmaceutical companies globally. AUM is the recipient of Frost & Sullivan’s 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year. For more information, please visit www.aumbiosciences.com